E. Tortoli, L. Rindi, A. Bartoloni, C. Garzelli, V. Manfrin, A

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

E. Tortoli, A. Bartoloni, C. Garzelli, N. Lari, F. Lavinia, A
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Molecular evolution of Mycobacterium tuberculosis
E. Tortoli, A. Bartoloni, C. Garzelli, N. Lari, F. Lavinia, A
L. Boyanova  Clinical Microbiology and Infection 
Gut bacterial microbiota and obesity
Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients 
Migrant health—a cause for concern?
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Hepatitis B and C virus-related carcinogenesis
Evidence of transmission of verocytotoxin-producing Escherichia coli O111 from a cattle stable to a child  E. Møller Nielsen, C. Jensen, D. Lau Baggesen 
Gentamicin susceptibility in Escherichia coli related to the genetic background: problems with breakpoints  L. Jakobsen, D. Sandvang, V.F. Jensen, A.M.
Molecular and phenotypic profiling of sorbitol-fermenting Escherichia coli O157:H− human isolates from Finland  M. Eklund, M. Bielaszewska, U.-M. Nakari,
R. Cantón  Clinical Microbiology and Infection 
Genital Chlamydia trachomatis infections
E. Cambau, M. Drancourt  Clinical Microbiology and Infection 
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia  D. Kese, M. Maticic, M. Potocnik  Clinical.
Non-antibiotic strategies for sepsis
Impact of immigration on tuberculosis in a low-incidence area of Italy: a molecular epidemiological approach  C. Garzelli, N. Lari, B. Cuccu, E. Tortoli,
Nosocomial bloodstream infections in children: an 8-year experience at a tertiary-care hospital in Finland  E. Sarvikivi, O. Lyytikäinen, M. Vaara, H.
Escherichia coli native valve endocarditis
Vector control: a cornerstone in the malaria elimination campaign
Pharmacodynamics of doxycycline
E. Tortoli, P. G. Rogasi, E. Fantoni, C. Beltrami, A. De Francisci, A
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Characterization of Mycobacterium tuberculosis isolated from cancer patients with suspected tuberculosis infection in Egypt: identification, prevalence,
Training for the infectious diseases speciality in Norway
M.N. Al-Hasan, B.D. Lahr, J.E. Eckel-Passow, L.M. Baddour 
Epidemiology of opportunistic infections in AIDS patients
B. Gordts  Clinical Microbiology and Infection 
Levofloxacin in the treatment of ventilator-associated pneumonia
Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region  K.B. Laupland, D.B. Gregson, D.L. Church,
Metagenomics and probiotics
L. Vogel, E. van Oorschot, H.M.E. Maas, B. Minderhoud, L. Dijkshoorn 
Hepatitis B and C virus-related carcinogenesis
The practice of travel medicine in Europe
T.M. File  Clinical Microbiology and Infection 
Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum β-lactamases  L. Romero, L. López,
Update on antifungal resistance in Aspergillus and Candida
Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union  S. Bronzwaer  Clinical.
Abstracts cont. Clinical Microbiology and Infection
Pandemic lineages of extraintestinal pathogenic Escherichia coli
Molecular epidemiology and virulence factors of pyogenic liver abscess causing Klebsiella pneumoniae in China  Y. Luo, Y. Wang, L. Ye, J. Yang  Clinical.
Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida 
A.P. Underwood, J. Green  Clinical Microbiology and Infection 
Antimicrobial drug development – the past, the present, and the future
H. Leblebicioglu, C. Eroglu  Clinical Microbiology and Infection 
C. Gagliotti, L. Nobilio, M.L. Moro 
An after-hours clinical liaison blood culture service—is it worth it?
Statin use and clinical outcomes among pneumonia patients
I. Bitar, A. Piazza  Clinical Microbiology and Infection 
Changing pattern of candidaemia 2001–2006 and use of antifungal therapy at the University Hospital of Vienna, Austria  E. Presterl, F. Daxböck, W. Graninger,
Antibiotic resistance patterns of more than clinical Escherichia coli isolates in Southeast Austria, 1998–2013  A. Badura, G. Feierl, G. Pregartner,
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin 
Abstracts Clinical Microbiology and Infection
Modelling during an emergency: the 2009 H1N1 influenza pandemic
Are we losing the fight against malaria one more time?
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
Localized Mycobacterium avium complex infection in a patient on HAART
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Isolation of a novel sequevar of Mycobacterium flavescens from the synovial fluid of an AIDS patient  E. Tortoli, L. Rindi, A. Bartoloni, C. Garzelli, V. Manfrin, A. Mantella, P. Piccoli, C. Scarparo  Clinical Microbiology and Infection  Volume 10, Issue 11, Pages 1017-1019 (November 2004) DOI: 10.1111/j.1469-0961.2004.00947.x Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Alignment of 16S rDNA, including the hypervariable region A, from FI-28796, Mycobacterium flavescens, Mycobacterium brumae and Mycobacterium goodii, commencing with position corresponding to base 118 on the Escherichia coli 16S rDNA. sqv., sequevar. Clinical Microbiology and Infection 2004 10, 1017-1019DOI: (10.1111/j.1469-0961.2004.00947.x) Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 2 Representative HPLC patterns of FI-28796, Mycobacterium flavescens, Mycobacterium brumae and Mycobacterium goodii. LMMIS, low molecular mass internal standard; HMMIS, high molecular mass internal standard. Clinical Microbiology and Infection 2004 10, 1017-1019DOI: (10.1111/j.1469-0961.2004.00947.x) Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions